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revious in vitro studies using cGMP or cAMP revealed
a cross-talk between signaling mechanisms activated
by axonal guidance receptors. However, the molecular
elements modulated by cyclic nucleotides in growth cones
are not well understood. cGMP is a second messenger with
several distinct targets including cGMP-dependent protein
kinase I (cGKI). Our studies indicated that the 
 

 
 isoform of
cGKI is predominantly expressed by sensory axons during
developmental stages, whereas most spinal cord neurons
are negative for cGKI. Analysis of the trajectories of axons
within the spinal cord showed a longitudinal guidance defect
of sensory axons within the developing dorsal root entry
P
 
zone in the absence of cGKI. Consequently, in cGKI-deficient
mice, fewer axons grow within the dorsal funiculus of the
spinal cord, and lamina-specific innervation, especially by
nociceptive sensory neurons, is strongly reduced as deduced
from anti-trkA staining. These axon guidance defects in
cGKI-deficient mice lead to a substantial impairment in
nociceptive flexion reflexes, shown using electrophysiology.
In vitro studies revealed that activation of cGKI in embryonic
dorsal root ganglia counteracts semaphorin 3A–induced
growth cone collapse. Our studies therefore reveal that
cGMP signaling is important for axonal growth in vivo and
in vitro.
 
Introduction
 
The formation of precise and selective connections between
neurons is essential for the function of the mature nervous
system. During development, the integration of several distinct
signals mediated by guidance receptors contributes to the
pathfinding of axons toward their targets to establish synapses
(Tessier-Lavigne and Goodman, 1996; Mueller, 1999;
Raper, 2000; Klein, 2001). Previous in vitro studies using a
growth cone turning assay indicated that signaling cascades
activated by axonal guidance receptors could be modulated
by cyclic nucleotides (Song et al., 1997; Hopker et al., 1999;
Song and Poo, 1999). For example, increasing levels of
 
cGMP converted a repulsive axonal growth of 
 
Xenopus
 
 spinal
neurons induced by semaphorin 3A into an attractive extension
and protected cultivated rat sensory growth cones from collapse
(Song et al., 1998). However, the intracellular components
activated by cGMP and whether cGMP signaling is also impor-
tant for growth cone decisions in vivo remained unknown.
In many cell types, cGMP is a widely used second messenger
that has several distinct targets (Hofmann et al., 2000; Lucas
et al., 2000), including activation of cGMP-dependent protein
kinase I (cGKI)* and cGKII, regulation of cAMP levels
through the activation or inhibition of cAMP-dependent
phosphodiesterases, and opening of cyclic nucleotide-gated
cation channels. cGMP is generated by soluble and particulate
guanylyl cyclases (Gibson and Garbers, 2000) and degraded
by phosphodiesterase V. The serine/threonine kinases cGKI
and II, of which cGKI is known to be expressed in the devel-
oping spinal cord (Qian et al., 1996), are composed of an
NH
 
2
 
-terminal domain, a regulatory segment, and a catalytic
domain. In mammals, cGKI is expressed in two alternatively
spliced isoforms, termed 
 

 
 and 
 

 
, that differ in their NH
 
2
 
-
terminal domains (Pfeifer et al., 1999). These NH
 
2
 
-terminal
stretches regulate homodimerization, cGMP affinity and
activation of the catalytic domain, and the substrate binding/
anchoring of the isoenzymes. cGKI, which has been investi-
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gated extensively in the context of regulation of smooth
muscle tone, has a variety of pleiotropic cellular regulatory
functions, including calcium release (Schlossmann et al.,
2000) and myosin phosphatase activation (Surks et al.,
1999). Here, we have analyzed whether cGKI is implicated
in growth cone steering in vitro and in vivo. Our results in-
dicate that cGKI
 

 
 is important for growth cone extension in
the dorsal root entry zone (DREZ) of the spinal cord and
counteracts semaphorin 3A–induced growth cone collapse
in vitro. We therefore demonstrated that cGMP signaling is
important for axonal pathfinding in vivo and that cGMP
signaling is mediated via cGKI
 

 
. Furthermore, physiological
investigations indicated that pathfinding errors of sensory
axons caused by the absence of cGKI resulted in a significant
impairment of the nociceptive flexion reflex.
 
Results
 
cGKI
 

 
, but not cGKI
 

 
, is selectively expressed in 
sensory axons of the developing spinal cord
 
To study a possible function of cGKI in axonal guidance in
vivo, we first examined the expression of both cGKI iso-
forms in axons of the embryonic dorsal root ganglion
(DRG) and the spinal cord. Western blots of extracts of em-
bryonic day 13 (E13) DRGs using polyclonal antibodies di-
rected to both isoforms or antibodies that distinguish be-
tween both isoforms demonstrated that the 
 

 
 isoform of
cGKI is expressed whereas the 
 

 
 isoform remains undetect-
able (Fig. 1 a). Immunostaining of cryostat sections with
these three different antibody preparations revealed a very
restricted pattern of expression of cGKI. cGKI
 

 
 is expressed
in cell bodies and growing axons of DRG neurons (Fig. 1,
b–g), and sensory axons at the DREZ were especially heavily
labeled for cGKI
 

 
. At more advanced stages, the entire dor-
sal funiculus and the descending collaterals of the proprio-
ceptive and, more weakly, of the nociceptive neurons were
also stained at E14 (Fig. 1, e and f). The labeling intensity
declined in the dorsal funiculus at more advanced develop-
mental stages (Fig. 1 g). Spinal neurons and axonal tracts
were not cGKI positive, however weak transient labeling was
observed in motoneurons at earlier developmental stages
(Fig. 1, b and c, arrowheads) and in preganglionic neurons.
In addition, cGKI
 

 
 appeared ideally situated to transduce
signals in growing sensory axons, as punctate cGKI immu-
noreactivity could be observed in the filopodia and lamelli-
podia of DRG neuron growth cones in culture (Fig. 1 h).
This very restricted spatio-temporal expression profile of
cGKI
 

 
 in sensory axons suggested that cGKI
 

 
 might regu-
late growth and pathfinding of DRG axons in specific re-
gions in vivo, in particular at the DREZ.
 
The longitudinal growth of sensory axons is impaired 
in the DREZ in the absence of cGKI
 
To investigate whether cGMP signaling via cGKI is impor-
tant for axonal pathfinding in vivo, and because cGKI
 

 
 is
restricted to sensory axons at early developmental stages, we
analyzed the trajectory of sensory axons within spinal cords
of cGKI-deficient embryos (Wegener et al., 2002) (see Fig. 6
b) in whole mounts and in transverse as well as horizontal
sections. Once sensory axons arrive at the DREZ of the de-
veloping spinal cord, each axon bifurcates into a rostral and
caudal branch extending over several segments without
Figure 1. cGKI is selectively expressed in developing DRG axons. (a) Western blot analysis demonstrates the presence of the , but not the 
, isoform of cGKI in embryonic DRGs. Lane 1, antibodies to both cGKI isoforms (c, common); lane 2, antibodies to the  isoform; lane 3, 
antibodies to the  isoform. For comparison, a blot of antibodies to L1 is shown. (b–h) Immunohistochemical detection of cGKI. (b–d) cGKI 
distribution in the E11–E13 spinal cord. cGKI is expressed in the DREZ and the developing dorsal funiculus as well as weakly and transiently 
on motoneuron columns (arrowheads) and in preganglionic neurons. Bar, 100 m. (e) cGKI expression in proprioceptive collaterals in the 
dorso-medial spinal cord at E14. Bar, 50 m. (f) cGKI expression in nociceptive collaterals in the dorso-lateral spinal cord at E14. (g) cGKI 
distribution in the E15 spinal cord. Bar, 100 m. (h) cGKI is distributed throughout a cultivated DRG growth cone. Bar, 5 m. Sections were 
either stained by antibodies recognizing both isoforms of cGKI (E11, E12, and E13) or only the  isoform (E14 and E15). Both antibody 
preparations gave identical results. Tissue sections of cGKI-deficient mice did not stain with antibodies against cGKI (unpublished data). 
D, drg; R, dorsal root; Z, DREZ.
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growing into the gray matter (Davis et al., 1989; Eide and
Glover, 1995; Mirnics and Koerber, 1995, 1997; Ozaki and
Snider, 1997). After a waiting period, collaterals grow out
from these longitudinal axons and form lamina-specific pro-
jections in the gray matter (Fig. 2 a). As expected from the
localization, the absence of cGKI in cGKI-deficient mice did
not affect the overall structure of the spinal cord and the
DRGs or their dorsal roots (unpublished data). To visualize
the growth in rostral/caudal direction within the spinal cord,
we used the lipophilic axonal tracer DiI (Honig and Hume,
1989) to label primary afferents in preparations of E12 or
E13 embryos fixed in paraformaldehyde. Whole mounts
were analyzed after 2, 3, and 4 d of incubation with a fluo-
rescence microscope. Whereas wild-type DRG axons ex-
tended a rostral and caudal branch with an equal frequency
(24 DRGs analyzed), DRG axons in mutant mice had a
strong preference for growing primarily in a rostral direction
(67% of 24 DRGs from 13 mutant embryos) (Fig. 2 b; Ta-
ble I). A confocal microscopic analysis of these DiI-labeled
preparations revealed that wild-type fascicles of dorsal roots
were split into a very fine meshwork within the DREZ, as
would be expected from the formation of T-like branches
that are laying on top of each other (Fig. 2 c, left). In con-
trast, in mutant embryos, thick fascicles of axons turning ei-
ther caudally or, preferentially, in a rostral direction were
observed (Fig. 2 c, middle and right). In summary, these ob-
servations indicate a defect of the mutant DRG axons within
the DREZ in rostral/caudal growth.
 
To describe selectively the trajectory of nociceptive sen-
sory axons within the spinal cord, we analyzed serial trans-
verse as well as horizontal sections of mutant and wild-type
embryos stained with antibodies to the NGF receptor trkA.
Axon bundles positive for trkA, observed at E10.5 at trunk
levels where sensory axons had just arrived at the DREZs,
were disorganized and divided into several spots in cGKI-
deficient mice, which represent axon fascicles in a cross sec-
tion. In contrast, in wild type, trkA-positive fascicles had a
compact and oval-shaped appearance (Fig. 3, a and b, arrow-
heads). In horizontal sections through the most ventral part
at the same trunk level of the mutant E10.5 DREZ, axon
fascicles had grown into the gray matter toward the midline
and then turned rostrally (Fig. 3 c). These fascicles lacked a
caudal arm of similar size if traced back in serial sections (un-
published data). This indicated that trkA-positive axons in
cGKI mutant mice have difficulties identifying their correct
path as soon as they reach the DREZ. At more rostral levels
of the body where more axons had already arrived and
growth in the rostro/caudal direction is more advanced at
E10.5, many trkA-positive axon fascicles were observed in
horizontal sections to grow directly to the central canal from
the DREZ in mutants (Fig. 3 e, arrowheads). Later in devel-
opment (E12–E13), the DREZ appeared more similar to
wild-type in transverse sections but had a reduced dorsal me-
dial extension in the cGKI-deficient spinal cord (Fig. 3, f
and g). At E14, the dorsal funiculus flattened out further in
wild-type embryos, whereas in cGKI-deficient mice, a dor-
Figure 2. Longitudinal growth of sensory axons is impaired in the spinal cord of cGKI-deficient mice. (a) Schematic drawing of the three-
dimensional morphology of a single sensory neuron within the spinal cord. (b) To visualize the longitudinal branching, primary afferents in 
preparations of E12 or E13 embryos were labeled with the lipophilic axonal tracer DiI (Honig and Hume, 1989). Whole mounts were analyzed 
laterally with a fluorescence microscope. Whereas wild-type (/) DRG axons branch equally in rostral and caudal direction, cGKI-deficient 
(/) DRG axons have a strong preference for growing primarily in rostral direction (to the right). Fluorescence images were inverted. 
Bar, 100 m. (c) Three adjacent confocal images of DiI-labeled axons of wild-type (/) and mutant mice (/) within the DREZ are shown. 
Note that mutant axons turn preferentially rostrally as bundles. Bar, 100 m. D, DRG; R, dorsal root.
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sally bifurcated appearance of the dorsal funiculus increased
(Fig. 3, h and i) and trkA-positive axon fascicles left the
lower arm of the developing dorsal funiculus, growing di-
rectly dorsal medially to the central canal (Fig. 3 i, arrow-
heads), most likely without branches in the rostral/caudal di-
rection. Taken together, the anti-trkA staining indicates
pathfinding errors of nociceptive axons at the DREZ. Other
axon systems within the spinal cord appear not to be affected
by the absence of cGKI. For example, commissural axons la-
beled by a mAb to TAG-1 grow correctly to the floor plate at
E11 (Fig. 3, l and m), and staining with anti-L1 antibodies,
a more general axon marker, indicated that the pattern of the
lateral, as well as of the ventral funiculus, is not affected in
mutant embryos (Fig. 3, j and k). The anti-L1 staining,
however, revealed the errors of nociceptive axons that ex-
tended directly to the central canal (Fig. 3 k, arrowheads).
An incorrect bifurcation at the DREZ, as observed by the
DiI tracing and anti-trkA staining, either due to an inability
to branch correctly or to maintain one axon from the T-like
branch point would result in a significant reduction of axon
numbers in the developing dorsal funiculus. We therefore
quantified the anti-trkA staining as a measure of axon num-
bers in transverse as well as in horizontal sections at different
trunk levels. These measurements indicated a 50–60% re-
duction of the trkA labeling in cGKI-deficient embryos in
comparison to wild type. Although axons have not been di-
rectly counted, this result suggested that substantially fewer
axons grew within the developing dorsal funiculus at E13
(Fig. 4 e), as would be expected from an incorrect T-like
branch formation or retention. At more advanced stages
(E15 and E16), the mutant dorsal funiculus was also consis-
tently thinner than in similar regions of wild-type mice.
Moreover, in mutant mice, the dorso-medial part of the dor-
sal funiculus (Fig. 4 d, arrows) never became populated by
trkA-positive axons throughout all spinal cord levels, which
again might reflect a reduction in axon numbers. To exclude
the possibility that this reduction of trkA-positive axons
within the spinal cord was caused by a loss of cells in the
DRG or by a decreased expression of trkA protein, cell num-
bers at E13 and E14 in L4 and L5 were determined and
Western blots of DRG extracts were analyzed with antibod-
ies to trkA. Neither a reduction in cell number nor a decrease
in trkA protein was observed in DRGs of cGKI-deficient em-
bryos in comparison to wild-type embryos (Fig. 4, f and g).
Collaterals of trkA-positive axons extended within the su-
perficial dorsal horn and displayed a similar pattern to that
of wild type. However, the intensity of trkA-positive fibers
within the superficial dorsal horn was substantially (50%)
 
Table I. 
 
Sensory axons of cGKI-deficient embryos reveal a longitudinal branching error within the DREZ
Embryo No. Genotype No. of injected DRGs
No. of DRGs with 
primarily rostral growth
No. of DRGs with equal 
bidirectional branching
 
E12
498-10
 

 
/
 

 
3 3 0
498-11
 

 
/
 

 
4 4 0
517-1
 

 
/
 

 
1 1 0
519-2
 

 
/
 

 
2 2 0
519-9
 

 
/
 

 
3 0 1
520-1
 

 
/
 

 
1 0 1
520-7
 

 
/
 

 
2 2 0
522-10
 

 
/
 

 
2 2 0
524-5
 

 
/
 

 
1 1 0
524-8
 

 
/
 

 
1 0 1
527-6
 

 
/
 

 
2 0 2
528-1
 

 
/
 

 
1 0 1
498-1
 

 
/
 

 
2 0 2
498-2
 

 
/
 

 
4 0 4
498-6
 

 
/
 

 
2 0 2
498-9
 

 
/
 

 
3 0 3
517-8
 

 
/
 

 
1 0 1
519-1
 

 
/
 

 
1 0 1
519-4
 

 
/
 

 
2 0 2
522-7
 

 
/
 

 
2 0 2
522-8
 

 
/
 

 
1 0 1
524-4
 

 
/
 

 
3 0 3
524-6
 

 
/
 

 
2 0 2
524-7
 

 
/
 

 
1 0 1
E13
483-1
 

 
/
 

 
1 1 0
483-4
 

 
/
 

 
2 1 1
483-5
 

 
/ 2 0 2
Number of DRGs labeled by DiI is given. The intensity of rostral and caudal segments within the spinal cord was measured in identical fields using NIH 
image software. The ratio of rostral/caudal staining varied from 1:0.51 to 1:0.85 in labeled DRGs with a primarily rostral growth in the absence of cGKI 
(mean value, 1:0.66  0.11). All others were considered as equal bidirectional growth. In wild-type DRGs, we observed a 1:1.02 ratio (mean).
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reduced in mutant mice (Fig. 4 e). The reduced innervation
of superficial laminae is probably a consequence of the re-
duced axon numbers available for the production of collater-
als from the stem axon within the dorsal funiculus. Because
cGKI was also expressed in the collaterals of proprioceptive
axons (Fig. 1 e), we followed the development of the propri-
oceptive axon collaterals in transverse serial sections using
parvalbumin as a marker. Although pathfinding appeared
unaffected in mutant embryos, fewer parvalbumin-positive
proprioceptive collaterals arrived in ventral spinal cord to in-
nervate motoneurons (Fig. 4, a and b).
Functional connectivity of spinal reflexes are impaired 
in cGKI-deficient mice
The longitudinal branching error, the decreased anti-trkA
staining, which might reflect a reduced axon number in the
dorsal funiculus, and the reduced innervation of the noci-
ceptive superficial dorsal horn by trkA-positive sensory fibers
in cGKI mutant mice prompted us to examine the func-
tional connectivity of sensory afferents in mutant mice. We
did this by using an in vitro spinal cord preparation (Fig. 5
a; Heppenstall and Lewin, 2001) to measure the integrated
ventral root potential in isolated postnatal day 5 (P5)–P9
spinal cord. We found that the fast motoneuron potential
evoked by electrical stimulation of large diameter afferents
was reduced in magnitude in cGKI mutant mice, but this
reduction of 40% did not reach statistical significance
(Fig. 5 c; t test, P  0.06). At higher stimulation intensi-
ties, a nociceptor-specific long-lasting ventral root potential
is evoked that represents activation of the nociceptive flex-
ion reflex. This potential was substantially (50%) and signif-
icantly reduced in cGKI mutant mice compared with wild-
type controls (Fig. 5, b–d) (P values and percentages refer
to integrated area of A-fiber and C-fiber response). We also
measured the activity-dependent facilitation of the ventral
root potential evoked by repetitive (1 Hz) stimulation of
nociceptive axons, a phenomenon termed wind-up. The
magnitude of the facilitation (percentage increase from
baseline) was unaltered in mutants, indicating that this
post-synaptic plasticity was largely intact (Fig. 5, e and f).
Thus, the defect in cGKI-mediated regulation of axon
guidance at the DREZ early in development leads to a loss
of functional connectivity that is selective for a pain-related
spinal reflex. The striking correlation we observed between
the anatomical and functional lack of sensory connectivity
suggested that the magnitude of the flexion reflex response
Figure 3. Pathfinding of nociceptive neurons is impaired in the DREZ of cGKI-deficient mice. trkA-positive axons were analyzed in transverse 
or horizontal sections of wild-type (/) and cGKI-deficient mice (/) at E12–E14. (a, b, f, g, h, i, j, k, l, and m) Transverse sections; 
(c, d and e) horizontal sections. The plane of transverse section used in a and b is shown in a cartoon in n. The plane of horizontal sections in 
c is indicated in o (the most ventral part of the DREZ), and the plane in d and e is indicated in p (center of the DREZ). (j–m) Staining of trans-
verse sections using polyclonal antibodies to L1 as a more general axon marker (j and k) or a mAb to TAG-1 to label commissural axons (l and 
m). These stainings indicate that the pattern of the lateral as well as the ventral funiculus and the growth of the commissural axons to the floor 
plate are not affected by the absence of cGKI. Arrowheads in e, g, i, and k point to axons or axon fascicles leaving the primordium of the dor-
sal funiculus of cGKI-deficient embryos to extend directly to the central canal. In transverse sections, dorsal is up, and in horizontal sections, 
rostral is up. Bars: (a–e) 10 m; (f and g) 50 m; (h–m) 100 m. C, central canal.
 o
n
 April 22, 2008 
w
w
w
.jcb.org
D
ow
nloaded from
 
494 The Journal of Cell Biology | Volume 159, Number 3, 2002
Figure 4. Quantitative analysis of proprioceptive and nociceptive 
axons within the developing spinal cord. (a–d) Less proprioceptive 
and nociceptive axons and their collaterals are observed in 
transverse sections of E15 cGKI-deficient than wild-type mice 
using parvalbumin (a and b) or trkA staining (c and d). Fluorescence 
images were inverted. In c and d, only the dorsal region of the 
spinal cord is shown. Arrowheads in a and b indicate parvalbumin-
positive collaterals. In d, the two arrows indicate dorso-medial 
regions not populated by trkA-positive axons. Bars, 100 m. 
(e) Quantification of trkA staining in transverse and horizontal 
sections at different levels of the spinal cord, which was taken as 
measure for axons growing in the developing dorsal funiculus at 
E13. The mean of the total pixel intensity of sections from wild-
type embryos at the thoracic level was taken as 100%. In horizontal 
sections, the staining intensity of serial sections of the total 
developing dorsal funiculus in three neighboring regions was 
summed. The intensity of staining in wild-type embryos was taken 
as 100%. The last two columns indicate quantitative measurements 
of four fields in the E15 dorsal superficial horn, the termination 
zone for nociceptive C-fibers. Error bars indicate standard 
deviations. (f) Sum of cell numbers in L4 and L5 DRG at E13 and 
E14 (black, wild type; white, cGKI-deficient embryos). The number 
of analyzed DRGs and embryos is indicated above each column. 
Error bars indicate standard deviations. (g) Western blot analysis 
of DRG extracts from wild-type and cGKI-deficient E13 embryos 
using polyclonal antibodies to trkA or, for comparison, to the Ig 
cell adhesion protein L1. The 145-kD component of trkA and the 
200-kD doublet of L1 are shown.
Figure 5. Impairment of the VRP of the spinal cord in the absence 
of cGKI. (a) In vitro–hemisected spinal cord preparation to measure 
monosynaptic and polysynaptic reflexes evoked by primary afferents. 
A scheme of a cross section of the spinal cord is shown and stimulating 
and recording electrodes are indicated. Dorsal is up. (b) VRPs of 
wild-type and cGKI-deficient neonatal mice. Electrical stimulation 
of dorsal root fibers generates a potential that can be recorded at the 
ventral root. The VRP is composed of a fast component evoked by 
A-fibers and a slower one activated by C-fibers (Heppenstall and 
Lewin, 2001). (c and d) Quantification of the VRP in wild-type and 
cGKI-deficient mice. The integrated area of the C-fiber area is 
significantly reduced in cGKI-deficient mice (P 	 0.05; n  6 per 
group). The integrated area of the A-fiber response was reduced but 
did not reach significance (P  0.06). (e) Wind-up in wild-type and 
cGKI-deficient neonatal mice. Repetitive electrical stimulation of 
dorsal root fibers (20 times, 1 Hz) evokes an increase in the potential 
recorded from the ventral root. (f) Quantification of wind-up in 
wild-type and cGKI-deficient mice. Wind-up, measured as the 
percentage increase in the potential, is not different between wild-
type and cGKI-deficient mice (P  0.7; n  6 per group).
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is limited by nociceptor connectivity within the superficial
spinal cord.
cGMP counteracts semaphorin 3A–induced growth 
cone collapse in vitro
Previous in vitro studies revealed that enhanced cGMP levels
modulate the collapse and turning behavior of growth cones
in response to semaphorin 3A (Song et al., 1998). To deter-
mine whether cGKI participates in the transduction of these
cGMP-mediated signals, DRGs explanted from wild-type
and cGKI-deficient mice were analyzed for semaphorin 3A–
mediated growth cone collapse. Under control conditions,
growth cone morphology of DRG neurons of cGKI-defi-
cient mice was indistinguishable from that of wild-type
mice. They spread well and have lamellipodia and filopodia.
We also did not observe any significant differences in neurite
length and fasciculation between explants from cGKI/
mice and wild-type littermates (Fig. 6 d; unpublished data).
Furthermore, the efficiency of the semaphorin 3A–induced
growth cone collapse was indistinguishable in wild-type
and cGKI-deficient DRG explants (Fig. 6, a and c). Using
membrane-permeable cyclic nucleotide analogues, we found
that raising cytosolic cGMP levels (with 8-pCPT-cGMP)
inhibited semaphorin 3A–mediated growth cone collapse in
wild-type, as described by Song et al. (1998), but not in
cGKI-deficient DRGs, whereas raising cAMP levels with
the analogue 8-Br-cAMP was without effect (Fig. 6, a and
c). Similar results were obtained with 8-Br-cGMP (1–5
mM; unpublished data). Neither 8-Br-cAMP nor 8-pCPT-
cGMP alone had any detectable effect on growth cones of both
genotypes (Fig. 6 a). Taken together, these in vitro studies in-
dicate that cGKI is not part of the semaphorin 3A–induced
signaling cascade that results in a collapse of growth cones,
but cGKI activation can counteract semaphorin 3A–induced
growth cone collapse of sensory axons.
Discussion
In this study, we have identified cGKI as a component of
the sensory axon growth cone machinery that transduces en-
dogenous cGMP changes required for correct sensory axon
guidance within the developing DREZ of the spinal cord.
Tracing with DiI and anti-trkA staining demonstrated that
sensory axons are unable to identify their correct path at the
entrance zone of the spinal cord and, as a consequence, are
unable to generate a rostral and caudal branch or, alterna-
tively, are unable to maintain one of the two branches. Evi-
dence for mistargeting of sensory axons in cGKI mutant
mice was observed by anti-trkA staining, as many axon fasci-
cles grow directly into the dorsal horn inappropriately in the
direction of the central canal most likely without the forma-
tion of a rostral or caudal axon. It is not possible with
present methods to distinguish whether cGKI-deficient sen-
sory axons are unable to branch at the DREZ or sustain two
branches indefinitely. As a consequence of this branching or
retention failure, the developing dorsal funiculus of mutant
mice was found to be smaller, and less collaterals were ob-
served that can project to lamina-specific targets in the dor-
sal and ventral horn. The longitudinal growth error is most
likely not due to a lack of axonal defasciculation in the
Figure 6. cGKI counteracts semaphorin 3A–induced growth cone 
collapse in vitro. (a) Growth cone collapse assay in the presence of 
8-pCPT-cGMP or 8-Br-cAMP using DRG explants from litter-
matched wild-type (/) or cGKI-deficient mice (/). The 
concentration and the presence of semaphorin 3A is indicated 
below the columns. The percentage of collapsed versus uncollapsed 
growth cones is presented and the number of counted collapsed 
growth cones and DRGs is given above the columns. The effect of 
semaphorin 3A alone was calculated as 100%. Error bars refer to 
SEM. Asterisk indicates significant difference from the samples 
without pretreatment with 8-pCPT-cGMP, P 	 0.001 (t test). 
(b) cGKI protein could be detected in Western blots of DRG of 
wild-type (/) but not in DRGs of cGKI-deficient (/) embryos 
using polyclonal antibodies directed to both isoforms of cGKI. 
(c) Growth cones from wild-type (/) or cGKI-deficient (/) 
mice in the presence of semaphorin 3A alone or semaphorin 3A 
and 0.5 mM 8-pCPT-cGMP. Neurons were stained by mAb A2B5 
for visualization and fluorescence images were inverted. DRGs from 
heterozygous (/) mice behaved as wild-type DRGs (unpublished 
data). Bar, 100 m. Note that growth cones in the bottom images 
are shown at a higher magnification than in the top images. Bar, 10 
m. (d) Outgrowth of DRG explants of cGKI-deficient mice (/) is 
indistinguishable from those of wild-type mice (/). Explants from 
lumbar regions of litter-matched E13 embryos grown for 24 h on 
laminin-1 were silver stained (Rager et al., 1979).
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DREZ, because sensory nerves of mutant mice do not ap-
pear more fasciculated outside the cord and in vitro–culti-
vated DRG axons do not generate thicker fascicles. The
preference for rostral growth within the DREZ in the ab-
sence of cGKI remains currently speculative. However, a
striking correlation was found between our anatomical and
functional investigations, and therefore, perhaps as a result
of early errors in sensory axon targeting in the DREZ, the
amplitude of the nociceptive flexion reflex is selectively and
substantially reduced in mutant mice. Thus axon targeting
errors have clear functional consequences for spinal reflex
circuit connectivity. The reduction in the sensory neuron to
dorsal horn connectivity we observed functionally probably
indicates that the reduction in the innervation of lamina II
by nociceptive sensory neurons is not compensated by an in-
creased number of synapses per sensory neuron. Interest-
ingly, plasticity of the nociceptive flexion reflex, termed
wind-up, is preserved, indicating that this largely post-syn-
aptic phenomenon (Herrero et al., 2000) is unaffected by
the reduced anatomical connectivity of C-fiber afferents
found in cGKI mutant mice. Early in development, cGKI
shows also a very restricted localization within the spinal
cord, and, consequently, pathfinding of other axon systems
was not affected by the absence of cGKI.
Previous in vitro assays indicated that cGMP can antago-
nize the semaphorin 3A–induced growth cone collapse
(Song et al., 1998). Our analysis of growth cone collapse us-
ing cGKI-deficient DRGs indicated that the activation of
cGKI mediates, in part, this counteracting effect of cGMP.
Because growth cones of cGKI-deficient DRGs collapse as
efficiently as wild-type DRGs, it can also be concluded that
cGKI is not part of the semaphorin 3A signaling pathway
that results in the collapse of sensory growth cones. This
contrasts with conclusions drawn from in vitro studies using
exclusively pharmacological reagents (Dontchev and Letour-
neau, 2002). Although semaphorin 3A has been described as
an in vitro branching factor for Xenopus retinal growth cones
but not for rat E17 DRG neurons (Wang et al., 1999;
Campbell et al., 2001), a possible counteracting effect by ac-
tivation of cGKI might not play a role for sensory path-
finding at the DREZ, as studies on semaphorin 3A– or neu-
ropilin-1–deficient mice have not reported sensory neuron
guidance defects similar to those we describe here (Kit-
sukawa et al., 1997; Taniguchi et al., 1997).
The guidance signals within the DREZ and the respond-
ing guidance receptor(s) on sensory axons whose activation
elevates intracellular cGMP and subsequently cGKI remain
to be determined. Slit2, a large extracellular matrix glycopro-
tein that acts as an axonal guidance signal for several axon
systems (Erskine et al., 2000; Niclou et al., 2000; Ringstedt
et al., 2000; Bagri et al., 2002; Plump et al., 2002), has also
been described as an in vitro branching factor for DRG neu-
rons growing on collagen (Wang et al., 1999). Although the
more general limitation of monolayer cell cultures does not
allow a definitive conclusion, most likely collateral branching
and not the formation of T-like branches were analyzed un-
der the experimental conditions described by Wang et al.
(1999), because relatively advanced DRG neurons from E17
rats were assayed. A recent study also suggested that cGMP
might modulate Slit2 signaling via cGKs (Nguyen-Ba-Char-
vet et al., 2001). However, in these investigations, the phar-
macological reagent KT5823 was used, which does not func-
tion as an inhibitor of cGKI in living cells, in contrast to in
vitro conditions (Burkhardt et al., 2000).
The analysis of downstream targets of cGKI might also
help to define the exact function of cGKI in sensory
growth cone steering at the DREZ further. In other cell
types outside the nervous system, cGKI lowers [Ca2]i by in-
terfering with intracellular calcium release (Schlossmann et
al., 2000) and/or activation of maxi KCa channels (Sausbier
et al., 2000), and may decrease myosin light chain phosphor-
ylation by interacting with the myosin targeting subunit of
myosin phosphatase (Surks et al., 1999) or by phosphoryla-
tion of RhoA, leading to its inactivation (Sauzeau et al.,
2000). Phosphorylation/dephosphorylation of the myosin
light chain regulates the cytoskeletal organization in many
cell types (Hall, 1998; Burridge, 1999) and could affect
filopodial extension in growth cones by modulating retro-
grade flow of actin filaments (Lin et al., 1996). In addition,
organization of cytoskeletal actin by cGKI in growth cones
of sensory axons might also occur by affecting the activity of
the actin organizing proteins VASP (Reinhard et al., 2001)
or CRP2 (Huber et al., 2000). Further studies will reveal
which, or whether a combination of these multiple down-
stream targets is regulated by cGKI in the DREZ.
Materials and methods
cGKI-deficient mice and quantification of the ventral root potential
The generation of a cGKI-null allele and mouse genotyping has been pre-
viously described (Wegener et al., 2002). Wild-type (/), heterozygous
(/), and cGKI-deficient (/) embryos were obtained from staged mat-
ings of heterozygous mice on a pure 129/Sv or mixed 129Sv/C57BL6 ge-
netic background. The measurement of the functional connectivity of
sensory afferents in spinal cord preparations was done using an in vitro–
hemisected spinal cord preparation (Heppenstall and Lewin, 2001). Spinal
cords were removed from neonatal mice (P5–P9), hemisected down the
midline, placed in a Perspex recording chamber, and superfused with oxy-
genated modified Krebs solution (138 mM NaCl, 1.35 mM KCl, 21 mM
NaHCO3, 0.58 mM NaH2PO4, 1.16 mM MgCl2, 1.26 mM CaCl2, 10 mM
glucose). DC recordings were made after a 2-h recovery period with a
close-fitting glass suction electrode attached to the L5 ventral root. Low in-
tensity electrical stimuli of the L5 dorsal root via a glass suction electrode
(50 A, 50 s) evoke fast short duration ventral root potential, as this stim-
ulus is selective for larger diameter A-fiber afferents. With higher intensity
stimuli that activate both A- and C-fiber afferents (500 A, 500 s), a long-
lasting slow ventral root potential (VRP) is evoked. Repetitive stimulation
at 1 Hz for 20 s produces a marked facilitation of the ventral root potential
amplitude (Fig. 5 e), and this is only observed when C-fiber afferents are
stimulated (Heppenstall and Lewin, 2001). The A-fiber– and C-fiber–medi-
ated components of the VRP were measured as the integrated area of the
response at 0–2 and 2–20 s, respectively. Wind-up was determined by nor-
malizing the increase in size of the VRP to the initial magnitude and ex-
pressing it as a percentage increase. Traces were acquired with the Power-
lab 4.0 system using Superscope software.
Immunodetection, DiI tracing, and DRG cell counting
For Western blotting, DRGs from E13 mice were collected, solubilized in
SDS-PAGE sample buffer, and separated by 10% SDS-PAGE. Equal loading
of lanes was confirmed by staining with antibodies to L1 (Rathjen and
Schachner, 1984). Rabbit antibodies specific to both isoforms, to the  or
 isoform of cGKI, were generated as detailed elsewhere (Schlossmann et
al., 2000). For immunohistochemical detection, cryostat sections of form-
aldehyde-fixed embryos were stained by indirect immunofluorescence us-
ing rabbit antibodies to cGKI (1:500 to 1:1,000), trkA (1:2,000; provided
by L. F. Reichardt, University of California San Francisco, San Francisco,
CA), parvalbumin (1:1,000; Calbiochem), TAG-1 (Dodd et al., 1988), or L1
(Rathjen and Schachner, 1984) followed by goat anti–rabbit or rabbit anti–
mouse antibodies coupled to Cy3 (Dianova). To detect intracellular local-
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ized cGKI, cultivated DRG neurons were fixed and permeabilized with
0.1% Triton X-100 before incubation with antibodies. For DiI (Molecular
Probes) tracing, mouse embryos were immersion fixed in 4% paraformal-
dehyde in PBS and stored in fixative until the application of axon tracer.
DiI dissolved in 100% ethanol was injected into single DRGs. The prepa-
rations were then incubated in 4% paraformaldehyde buffer at 37
C for
2–4 d. Whole mounts were viewed laterally using a confocal fluorescence
microscope (Bio-Rad Laboratories).
The intensity of trkA staining was quantified in serial horizontal sections
at E13 in three different defined fields in thoracic regions of the spinal cord
using NIH image software. The pixel intensity of each field of the complete
primordium of the dorsal funiculus (eight to nine serial sections of 20 m
thickness) was integrated, and the mean calculated and presented as rela-
tive units. In transverse sections, the trkA-stained area was delineated with
a mouse cursor to measure the area and the intensity in throracic and lum-
bar regions. Data from four to five adjacent sections of each level were
collected and the mean was calculated.
Cells from L4 and L5 DRG of E13 and E14 embryos were counted in se-
rial cryostat sections following methods previously described (ElShamy
and Ernfors, 1996; Farinas et al., 1996; Riethmacher et al., 1997). Sections
(14 m) were stained by the fluorescent Hoechst 33258 nuclear stain
(Spaltmann and Brummendorf, 1996). The maximum diameter observed
by this stain was 10 m, suggesting that the actual cell numbers might be
underestimated.
Growth cone collapse assay
For the growth cone collapse assay, we followed methods developed by
Raper and Kapfhammer (1990) using E13 DRG explants from the lumbar
region grown on poly-L-lysine/laminin-1 (GIBCO BRL) for 24 h in F-12
(GIBCO BRL) supplemented with hNGF- (20 ng/ml; Boehringer), N2 sup-
plement (GIBCO BRL), and bovine pituitary extract (200 g/ml; GIBCO
BRL) (Luo et al., 1993). Explants were pretreated with the indicated con-
centrations of 8-pCPT-cGMP, 8-Br-cGMP, or 8-Br-cAMP (BioLog) for 30
min followed by incubation with semaphorin 3A–containing culture su-
pernatants of transiently transfected COS7 cells for 1 h. Culture superna-
tants were titrated to induce a collapse of 90–100% of growth cones after
1 h. Glutaraldehyde-fixed explants were stained by mAb A2B5 (Develop-
mental Studies Hybridoma Bank) for visualization. cDNA encoding chick
semaphorin 3A (collapsin-1) (Luo et al., 1993) was obtained by RT-PCR
and subcloned without the signal sequence into a modified pSG5 vector
(Stratagene) containing the signal sequence of neurofascin (Volkmer et al.,
1992) followed by a myc and his tag. The cDNA sequence of the construct
was verified by DNA sequencing. A cDNA construct obtained from J.A.
Raper (University of Philadelphia, Philadelphia, PA) served as a control in
some experiments.
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